OneMedNet Lands High Six-Figure Add-On Order, Lifting Data Volume 150%
ONMD sits 20% above its 52-week low of $3.61 on light trading volume (0.2× avg).
Summary
OneMedNet booked a high six-figure add-on order from the precision medicine customer it signed a multiyear license with on September 30, 2026. The order exercises the expansion option in that agreement and raises data volume by 150%, coming only weeks after the original deal. The customer is building a licensable derivative dataset, and OneMedNet keeps source-data rights plus potential recurring sublicensing revenue on future end-customer licenses. For a company this small, a high six-figure repeat order is meaningful revenue validation and evidence the September agreement is scaling rather than one-and-done. It follows a stretch of insider buying in September and October and a 1-for-10 reverse split effective September 29, 2026, which cut the share count from roughly 60.1 million. Cash stood at just $0.4 million in the August 10-Q, so commercial traction of this kind matters for funding the business.
At the time of this announcement, ONMD was trading at $4.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $25.7M. The 52-week trading range was $3.61 to $23.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.